2 Promising Biotech Stocks That Insiders Are Snapping Up
Shares of Iovance Biotherapeutics and Reata Pharmaceuticals took it on the chin in the fourth quarter, but both companies seem ready to reward shareholders for their patience.
n Wednesday I discussed some criteria to follow in order to make small-cap selections in the biotech and biopharma spaces in the New Year In light of the recent volatility in the credit markets, it is more critical than ever to make sure small developmental firms have enough of a cash runway in place to avoid a financing crunch in the foreseeable ...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.